Zogenix, Inc. (ZGNX) Appoints James Breitmeyer To Its Board Of Directors
3/26/2014 9:31:12 AM
SAN DIEGO, March 26, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, announced today that James B. Breitmeyer, M.D., Ph.D., has been appointed as a new member of the Company's Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by